There are 2789 resources available
994P - PCR-based analysis of PD-L1 RNA expression in lung cancer: Comparison with commonly utilized immunohistochemical assays
Presenter: Evgeny Imyanitov
Session: ePoster Display
995P - A pan-cancer analysis of KMT2D as a potential biomarker for immune checkpoint therapy
Presenter: Xiaoqian Guan
Session: ePoster Display
996P - An immune-metabolic signature correlates with immune-suppressive patterns and with outcome, across tumor types
Presenter: Leire Pedrosa
Session: ePoster Display
997P - STK11 and KEAP1 mutational status and their impact in survival outcomes in non-small cell lung cancer patients treated with immune checkpoint inhibitors: Meta-analyses of clinical trials and cohort studies
Presenter: Gilberto De Castro Jr.
Session: ePoster Display
998P - Investigating the potential relationship between KRAS mutations and immunotherapeutic biomarkers in lung cancer (LC)
Presenter: Zhengbo Song
Session: ePoster Display
999P - NPC patients with post-RT EBV clearance show a higher frequency of peripheral CD8 T-cells expressing chemo-attractant receptors at baseline and during radiation therapy
Presenter: Shweta Mahajan
Session: ePoster Display
1000P - Screening cancer immunotherapeutic agents using high content imaging and analysis of immune-competent 3D InSight tumor models
Presenter: Francesca Chiovaro
Session: ePoster Display
Resources:
Abstract
1001P - A radiomics model for effective prediction of the treatment benefits of programmed cell death 1 inhibitors in advanced gastric cancer
Presenter: Ai Huang
Session: ePoster Display
1002P - Impact of pharmacodynamic biomarkers in phase I immune-oncology trials
Presenter: Abdulazeez Salawu
Session: ePoster Display
1003P - Expression by immunohistochemistry of p53 tumor suppressor protein as a predictive biomarker of response to immune checkpoint inhibitors in non-small cell lung cancer
Presenter: Alejandro Olivares Hernandez
Session: ePoster Display